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perceptual visual dysfunction in Nigeria:
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trial
Roseline Duke1,2* , Komomo Eyong3, Kathryn Burton4, David MacLeod2, Gordon N. Dutton5, Clare Gilbert1 and
Richard Bowman1
Abstract
Background: Cerebral visual impairment (CVI), including perceptual visual dysfunction (PVD), is common in children
with cerebral palsy (CP). Inventories of questions relating to practical aspects of visual perception in everyday life, in
particular the closed-ended Insight Questions Inventory (IQI), can be used to assess CVI/PVD. Studies linking
responses to the inventory with specific visual support strategies, aimed at modifying the child’s environment and/
or behaviour to minimize the impact of the CVI/PVD, have been piloted. The IQI and tailored strategies have not
been used in an African population, nor have they been tested in a controlled trial. This trial will compare the
effectiveness of the IQI and linked visual support strategies versus general supportive treatments on the quality of
life of children with CVI/PVD and CP through a randomized controlled trial.
Methods/design: This is a prospective, double-blind, parallel-arm, randomized controlled trial. The primary
outcome is change in quality of life scores between the two arms of the trial at 6 weeks, assessed using the
Paediatric Quality of Life Inventory (PedsQL) generic 4.0 and CP 3.0 module. All children will undergo baseline
assessment including the Open Questions Inventory, IQI, PedsQL 3.0, PedsQL 4.0 generic, and the Strengths and
Difficulties Questionnaire (SDQ). Eligible children with CP aged 4 years to < 16 years will be stratified and blocked by
the age groups 4–9 and 10 to < 16 years and by Gross Motor Function Classification System (GMFCS) levels 1–3 and
4–5. Families in the intervention arm will receive tailored insight visual support strategies and telephone calls
during the 6-week trial period. The control arm will receive standard treatment and the intervention after the 6-
week trial period. Follow-up interviews will be performed in both arms at 6 weeks with a repeat administration of
the PedsQL CP 4.0 and 3.0, the IQI and the SDQ. Secondary outcomes include a change in functional vision.
Discussion: This randomized controlled trial will provide evidence of the effectiveness of this intervention for
children with CP in a resource-poor setting.
(Continued on next page)
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Background
Cerebral palsy (CP) is the most common cause of motor
disability in children in low-income countries, affecting
the well-being of children and carers [1, 2]. It has a world-
wide incidence of about 2–2.5 per 1000 live births [1, 3,
4]. CP describes a group of permanent developmental dis-
orders of movement and posture causing activity limita-
tion, which are attributed to non-progressive disturbances
in the developing fetal or infant brain. In most individuals
with CP, the motor impairment is accompanied by sec-
ondary musculoskeletal problems, epilepsy, disturbances
of sensation, perception, cognition, communication, and
behaviour [5–7]. The definition of CP highlights that the
motor and visual impairments in CP are integral compo-
nents of the same disorder [5].
The diagnosis of CP is based on a clinical assessment
of history and examination [8]. For clinical and research
purposes, CP is classified by the nature of the movement
disorder (spasticity, ataxia, dystonia, and athetosis), and
the anatomic distribution of the motor abnormalities [7].
Current standardized classifications of CP include the
Gross Motor Function Classification System (GMFCS),
the GMFCS expanded and revised (E&R), the Manual
Ability Classification System (MACS), and the Communi-
cation Function Classification Scales (CFCS) [9, 10]. There
is currently no scale assessing visual or sensory function.
Facility-based studies on children with CP in Africa
have shown high rates of the more severe forms (using
GMFCS) of CP and associated conditions [11, 12], such
as epilepsy, learning disability, deafness, speech disor-
ders, visual impairment and malnutrition [13].
The development of normal vision takes place over the
first few years of life as anatomical structures and physio-
logical processes mature [14]. This occurs at the same
time as the development of language, emotion, motiv-
ation, and mental functions (which include cognition, so-
cial functions and the motor systems), which means that
poor visual function can affect these functions and vice
versa. Behaviour mirrors the cooperation and close inte-
gration of these functional systems [5, 15]. Mental and be-
havioural difficulties can be assessed using the Strengths
and Difficulties Questionnaire (SDQ), a screening tool for
3–16 year olds (not specific to CP). It has 25 items on psy-
chological attributes across five domains: emotional symp-
toms, conduct problems, hyperactivity/inattention, peer
relationship and pro-social behaviour [16].
Cerebral visual impairment (CVI), the most common
form of visual impairment in CP [17, 18], refers to loss
of visual function from lesions in pathways from the lat-
eral geniculate body and/or from the cortex to the
higher centres. The latter, known as the perceptual visual
system of the brain, includes the dorsal (occipito-par-
ietal) and the ventral stream functions (occipito-tem-
poral) [19, 20]. Lesions between the chiasm and cortex
can lead to loss of visual acuity and/or defects in the vis-
ual fields. Lesions in the perceptual visual systems give
rise to perceptual visual disorders (PVD) such as prob-
lems with face recognition, finding objects in a complex
visual environment, or orientation in space. These have
received little attention compared with loss of acuity or
the visual field, but studies have shown that PVD can
impact on a child’s ability to function using vision and
adversely affects quality of life [21–23]. The deficits in
CVI/PVD may be mild or severe, ranging from mild
PVD with normal visual acuity and visual fields, through
to complete loss of all visual function, depending on the
site(s) and severity of the lesion(s). The term CVI/PVD
is used to reflect the spectrum of disorders. Children af-
fected by CVI/PVD may also have intellectual and atten-
tional disorders.
As many brain functions are subconscious, such as vis-
ual guidance of movement and visual search, CVI/PVD
may be asymptomatic or go unrecognised. In addition,
in children with CP, motor deficits can mask disordered
visual guidance of movement. [23].
CVI/PVD can be suspected from observed visual behav-
iours, and becomes more apparent with age. The more se-
vere features can be assessed by 4–5 years [24]. Children
who do not have sufficient language or who are unaware of
their condition cannot report or comment on what they
can see or why vision is problematic and, therefore,
behaviour-based methods are used for assessment [25–27].
Although formal psychological testing may be helpful
in identifying children with CVI/PVD [28], the appropri-
ateness of psychological tests in a clinic setting is lim-
ited, and testing may be hindered by visual disorders
and other disabilities. The functional impact of CVI/
PVD can be identified by careful observation of behav-
iour, aided by structured history taking using open or
closed questions. Positive unprompted answers to non-
leading questions (open inventory) can be helpful in eli-
citing characteristic visual behaviours resulting from
Duke et al. Trials          (2019) 20:417 Page 2 of 12
severe visual impairment [29–31], visual field defects,
and cognitive and perceptual visual disorders, and has
been validated. Structured (closed questions) history tak-
ing using the Insight Questions Inventory (IQI), a 52-item
inventory which has been used in the UK, Bangladesh and
India [3, 14, 21, 30, 32], has been shown to be helpful; re-
sponses correlate with psychophysical tests of visual per-
ception and quality of life scores. In addition, the
responses lead to specific visual support strategies aimed
at modifying behaviour and/or the environment to com-
pensate for the visual problems and to minimize their im-
pact. The IQI assesses seven domains of visual function:
visual field, perception of movement, visual guidance of
movement, visual search, visual attention, recognition and
navigation, and behaviour in crowded environments. A
simple software program links inventory response to the
appropriate visual support strategies so that each child/
family has a set of recommended visual support strategies
(hereafter called IQI vision support strategies) specific for
that particular child. Despite anecdotal evidence that
parents find the inventory and strategies useful, there
is no clinical trial evidence of the effectiveness of
these strategies on improving visual function in every-
day life and quality of life compared with standard
ocular treatments such as the use of spectacles and
strabismus surgery when required.
Although closed questions lend themselves to specific
strategies, responses may be subject to cultural bias. In
this study, we will compare findings using the open and
closed questions. The use of targeted, tailored strategies
in the management of CVI is in line with patient-
centred care [33]. The parents and caregivers of the
child with CP and CVI are part of the decision-making
process, and implement the intervention. Several clinical
trials to improve the quality of life of children with CP
have been undertaken but none have addressed improve-
ment of visual function [34, 35].
The paediatric quality of life literature includes both
generic and condition-specific instruments. The Paediat-
ric Quality of Life Inventory (PedsQL) 4.0 generic core
scales encompass the following four areas of functioning:
physical (eight items); emotional (five items); social (five
items); and school (five items). It was used in a similar
cross-sectional study in Bangladesh in which 180 chil-
dren were recruited where 57 (32%) had visual acuity
impairment and 95 (53%) had some parent-reported
PVD. PVD was reported to be an important contributor
in reducing quality of life in children with CP, independ-
ent of motor disability and impaired visual acuity [21].
The 35-item PedsQL 3.0 CP module encompasses seven
scales: 1) daily activities (nine items); 2) school activities (four
items); 3) movement and balance (five items); 4) pain and
hurt (four items); 5) fatigue (four items); 6) eating activities
(five items); and 7) speech and communication (four items).
Rationale
The rationale of the study is to test the following hy-
potheses: 1) structured history taking from parents or
caregivers (hereafter referred to as carers) is an effective
way of determining whether children with CP have CVI/
PVD; and 2) if explained to carers and carefully applied,
visual support strategies, tailored to the question inven-
tory responses, can minimize the impact of CVI/PVD on
the child’s life and hence improve quality of life and
everyday visual function.
Methods
Aim
The aim of this study is to improve the management and
outcome of CVI/PVD in children aged 4 to less than 16
years of age with CP in a lower- to middle-income country.
Objectives
The objectives are: 1) to improve the management and
outcome of CVI/PVD in children aged 4 to less than 16
years of age with CP through the administration of the
IQI visual support strategies; 2) to determine the effect
on the quality of life and visual function of children aged
4 to less than 16 years of age with CP following the ap-
plication of specifically targeted IQI visual support strat-
egies compared with general supportive management in
Cross River State, Nigeria; and 3) to determine whether
the degree of motor or visual dysfunction is associated
with the degree of improvement in quality of life.
Trial design
This is a parallel group, double-blind clinical trial with
equal arm allocation, with a superiority design. This pro-
spective community study will be conducted in 18 local
government areas in Cross River State, Nigeria. The tar-
get population are children with CP, identified in the
community by key informants and confirmed by a paedi-
atric neurologist (see below). Figure 1 shows the SPIRIT
flow diagram for the effectiveness of visual support strat-
egies for visual impairment in children with CP showing
the enrolment, intervention and assessment.
Eligibility criteria
The inclusion criterion is children aged 4 to < 16 years
diagnosed with CP (by a paediatric neurologist using
standardized diagnostic criteria) [5] of any type or sever-
ity and their carers.
Exclusion criteria are children with other causes of
motor disorders, children whose carers refuse to partici-
pate, and children with CP who have debilitating illness
and require immediate medical care.
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Intervention
Intervention arm: selected IQI vision support strategies
The intervention is the application of some of the IQI
visual support strategies (Additional file 1) chosen by
the carers based on the “often” or “always” response to
the 52 IQI questions generated by the Insight software.
The social worker will explain and discuss the tailored
strategies with the carer, who will be asked to select
eight visual support strategies which they consider to be
the most important, relevant and practical to implement.
They will be asked to select one to three of the most im-
portant to start with, and those which could be imple-
mented thereafter. They will be advised to practise the
intervention three times a day. Carers will be given a list
of all the strategies they have selected. To improve ad-
herence and as part of the intervention, carers will be
contacted by a telephone call every 2 weeks (at 2, 4 and
6 weeks). Each telephone interview will be conducted by
the social worker to assess progress in implementing the
strategies, to identify challenges in implementation, and
to remind them of the additional strategies they selected
and encourage their application. A checklist of questions
will be used.
Control arm: no IQI vision support strategies
No intervention will be given during the 6 weeks after
recruitment. After week 6 follow-up assessment has
been completed, carers of children in the control arm
will be offered vision support strategies based on their
response to the IQI.
Follow-up
The trial period is 6 weeks. During the trial, telephone
calls will be made at weeks 2, 4 and 6.
Outcome measures
The primary outcome is a comparison of the change in
PedsQL 4.0 generic and 3.0 CP mean scores between
Enrolment Randomization Allocation Post-allocation 
(weeks)
Close-out
TIMEPOINT Pre-allocation 1 day after 
recruitment
3 days 
later
T1 T2 T4 T6 T7 tx
ENROLMENT
Eligibility screen X
RECRUITMENT
Informed consent X
Interviews [Open Question Inventory, IQI, 
PedsQL3.0 CP & PedsQL 4.0 Generic, SDQ]
X
Visual function tests X
Randomization X
Allocation X
INTERVENTIONS
Intervention arm: Insight vision support 
strategies + phone calls, 2nd, 4th, 6th week]
X X X X
Control arm
OUTCOMES at 6 weeks X
Interviews 
IQI, PedsQL3.0 CP & Generic 4.0, SDQ]
Both arms:
Standard therapy [glasses, wheel chair, 
strabismus surgery]
X
Control arm: 
Insight vision support strategies
X
CLOSURE X
Fig. 1 SPIRIT flow diagram. CP cerebral palsy, IQI Insight Questions Inventory, PedsQL Paediatric Quality of Life Inventory, SDQ Strengths and
Difficulties Questionnaire
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baseline and follow-up at 6 weeks between the two arms
of the trial. The PedsQL is being used as the primary out-
come measure because there is a clear conceptualization
of the health-related quality of life construct for children
in general and those with CP, which reflects concepts in
the assessment of PVD.
Secondary outcomes include change in functional vision,
using the mean scores in the IQI and the SDQ between
baseline and 6 weeks between the two arms of the trial.
Sample size calculation
Data from a pilot study in Bangladesh were used in the
sample size calculation. In the pilot study of 180 chil-
dren with CP, an improvement in quality of life as mea-
sured by PedsQL 4.0 generic of approximately 0.3
standard deviations (SD) was seen in the study popula-
tion [21]. Using the Altman nomogram [36], a sample
size of approximately 370 children with CP, with 185
children in each arm, is needed to detect an effect size
of 0.3 SD with 80% power and at 95% confidence, allow-
ing for 5% loss to follow-up.
Identification of study population and recruitment
Recruitment will take place over 12 months between
2017 and 2018. In the first stage, children with CP will
be identified in the community using the key informant
method. In the second stage, eligible children will be re-
cruited into the trial. Table 1 gives a general overview of
the research stages.
Identification of children with CP
A community-based sample of children with CP will be
identified and recruited to reduce the selection bias in-
herent in health facility-based studies. The key inform-
ant methodology (KIM) has been shown to be effective
for identifying children with severe visual impairment
and blindness and children with disabilities [37, 38], in-
cluding those with CP, in lower- to middle-income coun-
tries. The ten-question questionnaire has been validated
in an African community for use in the identification of
children with neurodevelopmental disorders including
CP [39]. The KIM involves identifying recommended,
respected community members who have had no previ-
ous medical training (for example, community leaders,
teachers, and local health or development workers). The
key informants will undergo 1 day of training by the
Principal Investigator (PI) using the ten-question ques-
tionnaire as a screening tool [39]. After training, they
will use a range of approaches to identify and list chil-
dren who might have CP over a 2-week period. Children
they identify and their carers will be invited to a pre-
agreed site, usually a primary health centre, for compre-
hensive history and detailed examination, including
neurological examination and confirmation of the
diagnosis and classification of CP by a paediatric neur-
ologist using diagnostic criteria [5]. Children with CP
who have debilitating illness will be referred immediately
to the tertiary health facility at the University of Calabar
Teaching Hospital and will not be recruited. The physio-
therapist will assess each child’s functions using the
GMFCS, MACS and CFCS, and determine the mobility
aids required [10]. Children who need wheelchairs and
ophthalmic interventions such as corrective glasses and
strabismus surgery will be scheduled for intervention
after the period of the study (it would not be feasible to
provide these sooner than 6 weeks even if the children
were not enrolled in the study).
Data on all eligible children (name, age and gender of
the child, and address and phone number(s) of carers)
will be entered into a password-protected database. Each
child will be allocated a unique identification number.
Informed consent and assent
Written informed assent will be obtained from carers and
consent from children who are old enough and who are
able to understand what is being asked of them. Consent
to participate in the interviews will also be taken from
carers. Consent will be obtained after a full verbal explan-
ation of the study has been given by a dedicated research
officer and the key informant who identified the child, an
information leaflet has been offered, and time allowed for
questions. The right of the child or carer to refuse to par-
ticipate without giving reasons will be respected, and it
will be made clear that carers and/or their child are free to
withdraw from the trial at any time without giving reasons
with no repercussions for them or their child. If carers
withdraw before randomization, another child will be re-
cruited. If a carer withdraws their child during the study,
reasons will be sought. Before giving assent, carers will be
informed that, should they subsequently withdraw, all the
data collected prior to their withdrawal will be maintained
and used for the purposes of the study. The PI will be re-
sponsible for ensuring that all participants are protected
and can participate voluntarily in an environment free
from coercion or undue influence.
Visual function tests
The CVI/PVD research questionnaire will be completed
by the ophthalmic nurse, optometrist and the paediatric
ophthalmologist. Sub-sections of the form include demog-
raphy, history, visual and motility assessments, and oph-
thalmological examinations including anterior segment
examination will be performed with a portable slit lamp
(Reichert Technology) and dilated posterior segment
examination will be performed by an ophthalmologist
using a binocular indirect ophthalmoscope (Appassamy)
with a 28D or 20D lens. Fundus photographs will be taken
using a Horous fundus camera. Visual fields will be
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assessed using the Lea wand. The following criteria for
prescribing glasses will be used: myopia ≥ −2.0D, hyper-
metropia ≥ +4 D, and astigmatic cylinder ≥ −2.0D. Table 2
shows the methods of assessment of visual function.
Assessment of CVI/PVD
CVI/PVD examination will be conducted using several
tests [40–43]. Table 3 describes the tests used to assess
CVI/PVD. Each observation has a score based on the abil-
ity or inability of a child to perform, and all will be under-
taken by the researcher (RD). The modified IQI, a 52-item
symptoms-based inventory, will be administered to each
carer to assess the nature of visual difficulties including
CVI/PVD in the children. There are seven sections, and re-
sponses to each question will use a five-point Likert scale
Table 1 Overview of methods at different stages in the trial
Before
randomization
After randomization
Intervention
arm
Control
arm
Before recruitment
Identification of children with
motor impairment in the
community
X
Examination to confirm
presence of CP
X
Examination to exclude
those ineligible
X
Eligibility confirmed X
Recruitment with informed
consent
X
After recruitment
Ocular examination (visual
function)
X
Distance visual acuity (Lea
symbols)
X
Near vision acuity (Lea
symbols)
X
Visual acuity (Peek/Peekaboo) X
Grating acuity (Lea paddles) X
Contrast sensitivity (Hiding
Heidi)
X
Colour vision assessment
(Ishihara chart)
X
Visual fields assessment (Lea
Flicker wand 280,000)
X
Stereopsis (Butterfly stereo
acuity test)
X
Extraocular motility
assessment
X
Vergence test X
Smooth pursuit assessment X
Saccades assessment X
Ocular alignment X
Assessment of
accommodation (near
pupillary reaction)
X
Cycloplegic refraction X
CVI/PVD assessment
(functional vision
assessment)
X
Visual fixation X
Visual guidance, colour,
visual memory
X
Visual guidance, 3D
recognition of concrete
objects
X
Visual recognition and line
orientation
X
Visual recognition of size, X
Table 1 Overview of methods at different stages in the trial
(Continued)
Before
randomization
After randomization
Intervention
arm
Control
arm
length and direction of lines
Visual attention X
Visual search X
Facial recognition X
Baseline interviews X
Open-questions inventory X
IQI inventory (closed
questions)
X
PedsQL 3.0 CP X
PedsQL 4.0 CP X
Strength and Difficulties
Questionnaire
X
Data management X
Data entered into database X
Randomization X
At baseline
IQI inventory X X
Strategies selected by carers X –
Telephone calls at 2, 4 and 6
weeks
X –
At 6 weeks
PedsQL 3.0 CP X X
PedsQL 4.0 generic X X
Strength and Difficulties
Questionnaire
X X
IQI Inventory (closed-
questions inventory)
X X
Strategies selected by carers – X
CP cerebral palsy, CVI cerebral visual impairment, IQI Insight Questions
Inventory, PedsQL Paediatric Quality of Life Inventory, PVD perceptual
visual disorders
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to describe whether a child has problems (“never”, “rarely”,
“sometimes”, “often”, or “always”, including “not applic-
able”). These responses will be awarded numbers from 1
to 5, respectively. The questions in each section are de-
signed to identify CVI/PVD. Visual tasks involve both the
dorsal and ventral visual streams functioning together;
however, the activities asked about in sections 1, 2, 3, 4
and 5 are designed to be illustrative of mainly dorsal visual
stream abilities whilst sections 6 and 7 rely more on ven-
tral stream function. The number of subjects with an arbi-
trarily set mean score of 3 or more for each or any section
will be recorded, indicating on average that the child had
problems with the tasks being asked about “sometimes”,
“often” or “always” and therefore had PVD. Questions
with more than half of respondents reporting “not applic-
able” will be excluded.
After examination, participants and their carers will disperse
to their homes and await further contact by telephone call.
Randomization
Baseline examinations are performed before randomization
so that stratification and blocking can occur and also so
that those collecting the baseline data are masked to the
allocation.
Sequence generation
The database of children recruited is accessible to the re-
searcher and contains information on their unique ID, age,
sex and GMFCS score. The database will be sent to the data
analyst in the University of Calabar Teaching Community
Medicine Department at the end of the examination per
consecutive local government area. Children will be stratified
and blocked by age groups 4–9 and 10 to < 16 years and by
GMFCS levels 1–3 and 4–5. The randomization sequence
will then be generated by the data analyst using the Stata 11
programming syntax for block randomization of patients
into the treatment and control group. The randomization
database will be password protected, and only accessible to
the data analyst. The randomization database holds data on
the patient’s unique ID, block number, block sizes and treat-
ment versus control groups. The data analyst will merge the
randomization database with the patient database using the
patients’ unique ID. The result of randomization in the com-
bined dataset will be sent to the research officer for the
Table 2 Visual function and tests to be performed
Visual function Test Performed
by
Presenting distance visual
acuity
Lea symbols Optometrist
Presenting distance visual
acuity
Peek visual acuity test; Peekaboo visual acuity test Optometrist
Presenting near visual
acuity
Reading
Lea symbols
Goodlite children’s reading chart
Optometrist
Optometrist
Grating acuity Lea paddles Optometrist
Contrast sensitivity Hiding Heidi Optometrist
Colour vision Acquired and congenital colour chart Optometrist
Visual fields Lea Flicker Wand 280,000 PI
Stereopsis Butterfly stereo acuity test with Lea symbols Optometrist
Eye movements PI
Vergence Observation of binocular movements of the eye, i.e. convergence and divergence, using a fixation target PI
Motion processing:
smooth pursuit (horizontal
and vertical)
Uncooperative or inattentive children are tested by slowly rotating a mirror that measures 10 cm by 15
cm held before their eyes
Verbal children: the patient is asked to track the tip of a blue ball point pen held 1 m before the eyes
with the head still; the target is moved at a low, uniform speed
PI
Motion processing:
saccades
Non-verbal: the infant or child is enticed to look at the tester’s face; when the fixation is in the midline,
one of the objects is presented at about 20–30 cm from the midline and the infant or child is again
enticed to look at the tester’s face after which the other object is presented on the other side.
Verbal: the patient is asked to look at the examiner’s nose and then at the examiner’s finger to the left or
right of central fixation only upon verbal command.
PI
Strabismus Corneal reflex test and modified Krimsky test PI
Accommodation Near pupillary reaction method PI
Cycloplegic refraction Cyclopentolate 2% + phenylephrine 2.5%
Zeiss autorefractor/keratometer
Manual objective retinoscopy
Optometrist
PI
PI Principal Investigator
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purposes of patient enrolment/allocation into the treatment
arm of the randomized clinical trial.
Allocation concealment and implementation
Carers of children assigned to the treatment arm of
the trial will be contacted by an independent
research clerk, who is masked to the baseline exam-
ination, by telephone call and also by the key in-
formant within 3 days of recruitment. Carers will be
invited to visit the same primary health centre where
the baseline examination was conducted at an agreed
time convenient to the carers. At this visit, the
Table 3 Assessment for CVI/PVD, corresponding test, observations, and grading by Principal Investigator
Subcategory of CVI/PVD Test Observation Grading
Visual fixation A fixation light is presented
before both eyes at a
distance of 0.75 m
Central, sustained or maintained Present (central, sustained and
maintained) or absent
Visual guidance, colour, eye–hand
coordination and visual memory
Lea 3D puzzle, coloured Eye–hand coordination and visual guidance
of movement: watching the movement a
child makes with their hand, elbow or
forearm when asked to turn over a piece of
puzzle; the ability to place the puzzle pieces
correctly
The capacity to orientate the shape is
subjectively viewed
Short-term memory for localization: can a
child place a piece of puzzle in the correct
place after being distracted
Easy, difficult, cannot do and
why, or not applicable
Visual guidance and 3D
recognition of concrete objects
Lea 3D puzzle, black and
white
Eye–hand coordination and visual guidance
of movement: watching the movement a
child makes with their hand, elbow or
forearm when asked to turn over a piece of
puzzle
3D assessment of an object; ability to place
the puzzle pieces correctly
Short-term memory for localization: can a
child place a piece of puzzle in the correct
place after being distracted
Easy, difficult, cannot do and
why, or not applicable
Visual recognition and line
orientation in three dimensions
(vertical, horizontal, oblique) and
eye–hand coordination
Lea mailbox game Visual perception of line orientation done
with the fingers, hand, or forearm:
• the child is asked to drop a card through
the slot of the LEA Mailbox Game
• the child is asked to match the orientation
of the slot
Easy, difficult, cannot do and
why, or not applicable
Visual recognition of differences in
size, length and direction of lines
Lea rectangles game Size, length perception:
• watch the orientation of the hand and
fingers as the child grasps a block
• can the child place a block of the same
length on top of another?
• can the child appreciate short and long as a
change in length?
• response to the enquiry concerning
whether a correct or an incorrect
arrangement looks the same
Easy, difficult, cannot do and
why, or not applicable
Yes, no, not sure, do not know,
not applicable
Visual attention Identification of self-
reflection in the mirror test
Pick-up test: picks up a small
ball of uniform size (1 mm)
placed on a patterned
surface
Identification of self-image
The distance at which the child loses interest
in self-image
Searches for and identifies the ball
Alert and attentive, alert but not
attentive, not alert, not attentive
Documentation of the distance
at which attention is lost; easy,
difficult, cannot do and why, or
not applicable
Visual search Pick-up test: picks up a small
ball of uniform size (1 mm)
placed on a plain or
patterned surface
Searches for and identifies the ball Easy, difficult, cannot do and
why, or not applicable
Facial recognition test Heide expression test Interpretation of facial expressions:
can the child interpret the facial expression?
Can the child identify a similar facial
expression?
Yes, no, cannot do, why or not
applicable
Easy, difficult, cannot do and
why, or not applicable
CVI cerebral visual impairment, PVD perceptual visual disorders
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intervention will be selected by the carers and ex-
plained to them by the social workers.
Contamination and masking
It is unlikely that contamination will occur as allocation
is not being done on the same day as the examination,
and carers of children in intervention and control arms
are unlikely to meet after the baseline assessment. The
research assistant who is not part of the initial examin-
ation will place telephone calls to carers within 3 days of
the examination. The data analyst involved in the se-
quence generation is not involved in any of the field
work. No member of the team collecting baseline data
will be involved in explaining the intervention nor in
collecting outcome data. Parents or carers who do not
respond to telephone calls will be personally contacted
by the key informant. Allocation is concealed to the PI
and all the members of the examination team. The
randomization sequence and allocation is computer gen-
erated and cannot be changed.
The week 6 outcome interviews will be performed by
a different set of researchers from those who collected
pre-intervention data. This follow-up assessment will be
from a mix of children in the intervention arm and in
the control arm attending on the same day.
Data collection methods
Interviewers will be trained for 6 weeks on data collec-
tion using the following study instruments: PedsQL3.0
CP, PedsQL4.0 generic, SDQ, IQI and strategies, and
strategy follow-up form.
Data will be collected at baseline and at the end of
follow-up after 6 weeks. Outcome data will be entered into
one Microsoft Excel database by a masked medical re-
cords officer who has no knowledge of, or access to, iden-
tifiable participant information or treatment assignment.
Open ended and IQI
All carers of children with CP will be interviewed with
both the open-ended questions inventories and then the
modified IQI at baseline, and at the end of 6 weeks only
with the modified IQI. Details of the IQI are shown
above (‘Assessment of CVI/PVD’).
Quality of life methodology
For the PedsQL 4.0 generic tool and the PedsQL CP 3.0
module, the parent’s proxy form will be used.
The 23-item PedsQL 4.0 generic core scales encom-
pass: 1) physical functioning (eight items); 2) emotional
functioning (five items); 3) social functioning (five
items); and 4) school functioning (five items). The 35-
item PedsQL 3.0 CP module is composed of seven
scales: 1) daily activities (nine items); 2) school activities
(four items); 3) movement and balance (five items); 4)
pain and hurt (four items); 5) fatigue (four items); 6) eat-
ing activities (five items); and 7) speech and communica-
tion (four items). The parents will be given a five-point
Likert response scale (1 = “never”, 2 = “almost never”, 3
= “sometimes”, 4 = “often”, 5 = “almost always”) to
choose one single option. The results will be entered on
the PedsQL form. The results from the questionnaire
will be transferred to an Excel sheet to number 0 to 4,
respectively. To interpret the scores, items are reverse
scored and linearly transformed to a 0–100 scale, so that
higher scores indicate better health-related quality of life.
To reverse the score, the 0–4 scale items will be trans-
formed to 0–100 as follows: 0 = 100, 1 = 75, 2 = 50, 3 =
25, 4 = 0. To create the scale scores, the mean will be
computed as the sum of the items over the number of
items answered (this accounts for missing data). The
number of missing values in the scale will be summed
and the item scores divided by the number of items in
the scale minus those that were missed. The mean psy-
chosocial health summary score will be computed as the
sum of the items over the number of items answered in
the emotional, social, and school functioning scales. The
total scale score, for both the generic and CP modules,
will be obtained by computing the mean as the sum of
all the items over the number of items answered on all
the scales [44]. If more than 50% of the items in the
scale are missing, the scale scores will not be computed.
If 50% or more items are completed then they will be
used to impute the mean of the completed items in a
scale according to PedsQL guidelines.
Strength and Difficulties Questionnaire
The SDQ is a brief emotional and behavioural screening
questionnaire for children and young people; the inter-
view will be conducted after the PedsQL 4.0 generic and
3.0 CP module and administered at the examination site.
The SDQ has 25 items on psychological attributes that
are divided between five scales: emotional symptoms,
conduct problems, hyperactivity/inattention, peer rela-
tionship, and pro-social behaviour. The parents/carers
will be given instructions to give their answers on the
basis of the child’s behaviour over the last 6 months.
The reports will be computer generated and optimized
by the ‘youthinmind’ team.
Data management
The Data Monitoring Committee, which is independent
of the sponsors, will provide oversight of the data collec-
tion process and will meet after recruitment has been
completed in each local government area. Two optome-
trists and two ophthalmologists will undergo compe-
tency training in clinical examinations to ensure
standardization of data collection methods and in com-
pleting the ophthalmic examination questionnaire. Two
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nurses will be trained on history taking using the open
questions inventory, and questionnaires including the
PedsQL 4.0 generic and 3.0 CP module and the SDQ.
Four social workers will be trained to administer the IQI
and strategies and follow-up form. Two nurses will be
trained to be part of the follow-up team for the week 6
follow-up assessment. Successful completion of compe-
tency training for all research staff will be confirmed by
a competency checklist.
Participant data will be stored securely, and their con-
fidentiality protected. Each participant will be given a
unique trial number at the end of the examination and
this will be used throughout the study to identify all data
relating to the participant. Data collected by all members
of the research team will be entered on paper then
transferred to a Microsoft Excel data sheet on a protec-
tion compliant drive in the research office. Question-
naires and inventory questions will be assessed at the
end of the research day. Where there are missing data,
every attempt will be made to complete the data. Data
will be entered the following morning. Data entry errors
will be corrected at the end of each following day. Data
will be updated to the Chief Investigator every day that
data are collected. All patient-identifiable information
will be kept on encrypted computers in a secure office,
with access limited to authorized members of the re-
search team. All data will be archived in secure archive
facilities in the London School of Hygiene & Tropical
Medicine (LSHTM) for 10 years. After this time, all
documentation will be kept in a general data pool in
LSHTM. The final dataset will initially be available only
to the study team. After the results of the trials have
been reported, the trial data will be made publicly avail-
able through the LSHTM repository.
Statistical methods
Missing data will be addressed at the analysis stage. Stat-
istical analyses will be conducted with STATA (version
14.0) as an intention-to-treat analysis. Our descriptive
statistics will include means and SD, medians and inter-
quartile ranges for continuous variables, and the number
and proportions for categorical variables as appropriate.
We will compare the two intervention groups at base-
line regarding characteristics and demographics using
two-tailed Student’s t tests and the effect size to test the
strength of the difference. Variables that differ between
the groups at baseline will be considered as possible
confounders and adjusted for in subsequent analyses.
The alpha level will be set at 0.05 for all comparisons.
We will use the unpaired (two-sample) t test for com-
paring the change in PedsQL 4.0 and 3.0 CP module
score and IQI score in arm 1 versus arm 2. Skewed data
will be analysed with non-parametric test alternatives
(e.g. we will use the Mann-Whitney U test instead of
Student’s t tests if data are skewed). We will use the
paired t test for comparing mean scores of PedsQL CP
4.0 and 3.0 CP module scores before and after interven-
tion. We will use the paired t test for comparing mean
IQI scores before and after the intervention. Potential ef-
fectors of PedsQL 4.0 and 3.0 CP module and IQI (visual
function) outcome, such as socio-demographics and all
medical and clinical variables (GMFCS, MACS, CFCS,
grade of vision, key CVI/PVD examinations and types of
CP) will all be investigated pairwise and those found to
be correlated will be entered into a multivariate regres-
sion model. We will undertake subgroup analysis on the
type of CP and what level of GMFCS showed improved
quality of life, and analysis by socio-demographic factors,
age, sex, type of CP, GMFCS, MACS, CFCS, visual acu-
ity, type of PVD by insight domain, and association with
ocular examinations.
Monitoring
Adverse events
Reported adverse events such as pain or distress will be
carefully monitored throughout the trial, although min-
imal risk is anticipated. Contacts for reports of adverse
reactions will be put in place and carers advised to re-
port to the study centre at the Calabar Childrens’ Eye
Center. Reporting of adverse events will follow LSHTM
guidelines on recording, managing and reporting adverse
events for behavioural interventions [45].
Loss to follow-up
Participants who do not respond to the 2-weekly tele-
phone calls by week 6 will receive a home visit from the
key informant, and the end of trial questionnaires will be
administered at their home by a member of the research
team. Participants who are lost to follow-up will be in-
cluded in the analysis.
Audit
Data will be reviewed at the end of the field work on a
daily basis. Random comparisons between entered data
and filled protocols will be performed after each five en-
tries. This will be done independently of the sponsors.
The study may be subject to audit by the LSHTM under
their remit as sponsor, the Study Coordination Centre
and other regulatory bodies to ensure adherence to
Good Clinical Practice (GCP).
Discussion
The Effectiveness of Visual Support Strategies for Visual
Impairment in Cerebral Palsy (EVSSCP) study will be
the first randomized controlled trial to investigate the ef-
fect of tailored visual support strategies for the treat-
ment of PVD in children with CP. Evidence-based
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management strategies for children with this problem
are urgently needed.
Considering the lack of awareness of visual support
strategies in the treatment of PVD and the need for
knowledge dissemination in this area, this trial should
lead to a significant advance in the management of this
condition.
All the children with CP are being recruited to the trial,
not just those with confirmed CVI. The reason for this is
that subtle visual problems are common in CP and since
detailed visual assessment is not always possible in prac-
tice it would be useful to have a tool that can be given to
all CP families. The tool is self-titrating in that if no visual
problems are reported in the IQI then no strategies will be
given. This could potentially reduce the power of the trial,
but if the tool is found to be useful for all children with
CP then it will be clinically more useful.
Although pilot data from Bangladesh has been encour-
aging, there has been no randomized controlled trial that
measures the effects of potentially effective visual sup-
port strategies in habilitating children with PVD. If it
were shown to be effective then it could be scaled up as
a community-based intervention.
Limitations
The EVSSCP trial is planned to be carried out as a single
country study and can, therefore, only be seen as a pre-
liminary study in Africa. In this study there are limita-
tions in the use of some examination methods [46].
Trial status
This is protocol version number 2 of 18/09/2016, and
recruitment began on 4 December 2017. Recruitment is
expected to be completed by the end of July 2018.
Additional file
Additional file 1: Modified Insight Questions Inventory (IQI) and tailored
visual support strategies. (DOCX 56 kb)
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